| Bioactivity | SLCB050 is a compound that blocks the interaction between DX2 and p14/ARF and has anticancer activity. SLCB050 reduces the viability of human lung cancer cells, especially small cell lung cancer cells, in a p14/ARF-dependent manner and induces apoptosis and senescence[1]. |
| CAS | 1848971-16-3 |
| Formula | C21H18O6 |
| Molar Mass | 366.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ah-Young, et al. "Inhibiting DX2-p14/ARF interaction exerts antitumor effects in lung cancer and delays tumor progression." Cancer Research 76.16 (2016): 4791-4804. |